Increased number of muscarinic binding sites in brain following chronic barbiturate treatment to rat.
D000818:Animals; D001462:Barbital / Q000008:administration & dosage / Q000494:pharmacology*; D001463:Barbiturates / Q000494:pharmacology*; D002531:Cerebellum / Q000032:analysis; D003342:Corpus Striatum / Q000032:analysis; D006624:Hippocampus / Q000032:analysis; D006801:Humans; D008297:Male; D008526:Medulla Oblongata / Q000032:analysis; D008636:Mesencephalon / Q000032:analysis; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D051381:Rats; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*; D012640:Seizures / Q000503:physiopathology; D013375:Substance Withdrawal Syndrome; D013574:Synaptosomes / Q000378:metabolism
D001463:Barbiturates; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D001462:Barbital; D011813:Quinuclidinyl Benzilate